Titan Biotech Ltd

NSE: TITANBIO · BSE: 524717 · Chemicals & Petrochemicals · 16 announcements

Share price: ₹384.95
Market cap: ₹1,591 Cr
Revenue (annual): ₹206.2 Cr
Net profit (annual): ₹29.89 Cr
P/E (TTM): 47.0×Sector 37.2×
Promoter holding: 55.78%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Board Meeting Date 3 Legal & Regulatory 1 Dividend 1 Debt & Borrowing 1 Bonus Issue 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 Apr 2026 15:59 IST BSE

Debt & Borrowing

Titan Biotech Debt & Borrowing

Titan Biotech Limited confirmed it is not classified as a Large Corporate for the financial year ended March 31, 2026. The company reported zero outstanding long-term borrowings under the SEBI framework. This annual disclosure is a routine compliance requirement for listed entities regarding debt market borrowing norms.

Read the filing ↗